Literature DB >> 17971730

1,4-Benzodiazepine N-nitrosoamidines: useful intermediates in the synthesis of tricyclic benzodiazepines.

Santos Fustero1, Javier González, Carlos del Pozo.   

Abstract

1,4-Benzodiazepine N-nitrosoamidines have been used as scaffolds for the preparation of different tricyclic derivatives. Replacement of the N-nitrosoamidine moiety through treatment with the nucleophiles acetylhydrazine, aminoacetaldehyde dimethylacetal and 1-amino-2-propanol, followed by an acid-catalyzed cyclization step, afforded triazolo and imidazobenzodiazepines 1, 6, and 7, respectively, in good yields. When acetylhydrazine is used as a nucleophile, the overall process provides an alternative route to alprazolam (1b) and triazolam (1c), respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17971730      PMCID: PMC6148486          DOI: 10.3390/11080583

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  6 in total

1.  Benzodiazepine receptor: demonstration in the central nervous system.

Authors:  H Möhler; T Okada
Journal:  Science       Date:  1977-11-25       Impact factor: 47.728

2.  Triazolobenzo- and triazolothienodiazepines as potent antagonists of platelet activating factor.

Authors:  A Walser; T Flynn; C Mason; H Crowley; C Maresca; B Yaremko; M O'Donnell
Journal:  J Med Chem       Date:  1991-03       Impact factor: 7.446

3.  1-(2-aminoethyl)-6-aryl-4H- [1,2,4]triazolo[4,3-a][1,4]benzodiazepines with diuretic and natriuretic activity.

Authors:  J B Hester; J H Ludens; D E Emmert; B E West
Journal:  J Med Chem       Date:  1989-06       Impact factor: 7.446

4.  8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines with substituents at C-4.

Authors:  J B Hester; A D Rudzik; P F Von Voigtlander
Journal:  J Med Chem       Date:  1980-06       Impact factor: 7.446

5.  1-(Aminoalkyl)-6-aryl-4-H-s-triazolo[4,3-a][1,4]benzodiazepines with antianxiety and antidepressant activity.

Authors:  J B Hester; A D Rudzik; P F VonVoigtlander
Journal:  J Med Chem       Date:  1980-04       Impact factor: 7.446

6.  2,4-Dihydro-6-phenyl-1H-s-triazolo[4,3-a][1,4]benzoidiazepin-1-ones with antianxiety and antidepressant activity.

Authors:  J B Hester; A D Rudzik; P VonVoigtlander
Journal:  J Med Chem       Date:  1980-04       Impact factor: 7.446

  6 in total
  4 in total

1.  Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.

Authors:  Rajkumar J Sevak; William W Stoops; Lon R Hays; Craig R Rush
Journal:  J Pharmacol Exp Ther       Date:  2008-12-22       Impact factor: 4.030

2.  An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals.

Authors:  Marcus Baumann; Ian R Baxendale; Steven V Ley; Nikzad Nikbin
Journal:  Beilstein J Org Chem       Date:  2011-04-18       Impact factor: 2.883

Review 3.  'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports.

Authors:  Laura Orsolini; John M Corkery; Stefania Chiappini; Amira Guirguis; Alessandro Vento; Domenico De Berardis; Duccio Papanti; Fabrizio Schifano
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

4.  Synthesis and biological evaluation of the new ring system benzo[f]pyrimido[1,2-d][1,2,3]triazolo[1,5-a][1,4]diazepine and its cycloalkane and cycloalkene condensed analogues.

Authors:  Mohamed El Haimer; Márta Palkó; Matti Haukka; Márió Gajdács; István Zupkó; Ferenc Fülöp
Journal:  RSC Adv       Date:  2021-02-10       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.